Sepsis Diagnostics - Global Market Outlook (2016-2022)

September 2016 | 138 pages | ID: S76E2E2D2EFEN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Sepsis Diagnostics market is accounted for $330.74 million in 2015 and is expected to reach $659.36 million by 2022 growing at a CAGR of 10.4%. This life-threatening condition of Sepsis arises when the body's response to infection injures its own tissues and organs; the rise in number of the situations is demanding more diagnostics. Rising health concerns such as Cancer, Diabetes, Major Trauma, and Burns etc. are depleting the immune system among all age groups, which has given rise to the demand for the Sepsis diagnostics market. Moreover, increasing surgical procedures, exponential rise in incidence of hospital-acquired infections and growth in the number of product approvals are supporting the growth of this market. On the other hand, lack of standard protocols and awareness and shortage of skilled staff are the hindering the same.

Blood Culture Media segment is expected to grow at par level owing to its standardized techniques for the Sepsis diagnostics. By Technology, Microbiology segment is estimated to be the largest growing segment in order to the increasing inclination of physicians and patients towards use of rapid diagnostic products for accurate and quick identification and diagnosis of sepsis. North America is dominating the global market owing to high prevalence of sepsis, rising number of invasive procedures, and rising government support towards sepsis researches. However, Asia Pacific is expected to be the fastest growing market owing to increasing number of surgical procedures, and growing number of clinical studies.

Some of the key players of the Sepsis Diagnostics market include Beckman Coulter (Danaher), Becton, Dickinson & Co. (BD), bioMerieux, Bio-Rad Laboratories, Bruker Corporation, Cepheid, Chembio Diagnostic Systems, Nanosphere, Inc., Ortho-Clinical Diagnostics, Roche Diagnostics, Siemens Healthcare Diagnostics, T2 Biosystems, Inc., Thermo Fisher Scientific, and Trinity Biotech.

Methods Covered:

• Automated Diagnostics
• Conventional Diagnostics

Products Covered:

• Assay Kits & Reagents
• Blood Culture Media
• Instruments
• Software

Pathogens Covered:

• Fungal Sepsis
• Bacterial Sepsis
• Gram-Negative Bacterial Sepsis
• Gram-Positive Bacterial Sepsis
• Other Pathogens

Technologies Covered:

• Flow Cytometry
• Immunoassays
• Microbiology
• Molecular Diagnostics

Applications Covered:

• Laboratory Testing
• Point-Of-Care Testing

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 Emerging markets

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY METHOD

5.1 Introduction
5.2 Automated Diagnostics
5.3 Conventional Diagnostics

6 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PRODUCT

6.1 Introduction
6.2 Assay Kits & Reagents
6.3 Blood Culture Media
6.4 Instruments
6.5 Software

7 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN

7.1 Introduction
7.2 Fungal Sepsis
7.3 Bacterial Sepsis
  7.3.1 Gram-Negative Bacterial Sepsis
  7.3.2 Gram-Positive Bacterial Sepsis
7.4 Other Pathogens

8 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY

8.1 Introduction
8.2 Flow Cytometry
8.3 Immunoassays
8.4 Microbiology
8.5 Molecular Diagnostics

9 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY APPLICATION

9.1 Introduction
9.2 Laboratory Testing
9.3 Point-Of-Care Testing

10 GLOBAL SEPSIS DIAGNOSTICS MARKET, BY GEOGRAPHY

10.1 North America
  10.1.1 US
  10.1.2 Canada
  10.1.3 Mexico
10.2 Europe
  10.2.1 Germany
  10.2.2 France
  10.2.3 Italy
  10.2.4 UK
  10.2.5 Spain
  10.2.6 Rest of Europe
10.3 Asia Pacific
  10.3.1 Japan
  10.3.2 China
  10.3.3 India
  10.3.4 Australia
  10.3.5 New Zealand
  10.3.6 Rest of Asia Pacific
10.4 Rest of the World
  10.4.1 Middle East
  10.4.2 Brazil
  10.4.3 Argentina
  10.4.4 South Africa
  10.4.5 Egypt

11 KEY DEVELOPMENTS

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 COMPANY PROFILING

12.1 Abbott Diagnostics
12.2 Beckman Coulter (Danaher)
12.3 Becton, Dickinson & Co. (BD)
12.4 bioMerieux
12.5 Bio-Rad Laboratories
12.6 Bruker Corporation
12.7 Cepheid
12.8 Chembio Diagnostic Systems
12.9 Nanosphere, Inc.
12.10 Ortho-Clinical Diagnostics
12.11 Roche Diagnostics
12.12 Siemens Healthcare Diagnostics
12.13 T2 Biosystems, Inc.
12.14 Thermo Fisher Scientific
12.15 Trinity Biotech

List Of Tables

LIST OF TABLES

1 Global Sepsis Diagnostics market, By Region (2013-2022) ($MN)
2 Global Sepsis Diagnostics market, By Animal type (2013-2022) ($MN)
3 Global Sepsis Diagnostics market, By Method (2013-2022) ($MN)
4 Global Sepsis Diagnostics market, By Automated Diagnostics (2013-2022) ($MN)
5 Global Sepsis Diagnostics market, By Conventional Diagnostics (2013-2022) ($MN)
6 Global Sepsis Diagnostics market, By Product (2013-2022) ($MN)
7 Global Sepsis Diagnostics market, By Assay Kits & Reagents (2013-2022) ($MN)
8 Global Sepsis Diagnostics market, By Blood Culture Media (2013-2022) ($MN)
9 Global Sepsis Diagnostics market, By Instruments (2013-2022) ($MN)
10 Global Sepsis Diagnostics market, By Software (2013-2022) ($MN)
11 Global Sepsis Diagnostics market, By Pathogen (2013-2022) ($MN)
12 Global Sepsis Diagnostics market, By Fungal Sepsis (2013-2022) ($MN)
13 Global Sepsis Diagnostics market, By Bacterial Sepsis (2013-2022) ($MN)
14 Global Sepsis Diagnostics market, By Gram-Negative Bacterial Sepsis (2013-2022) ($MN)
15 Global Sepsis Diagnostics market, By Gram-Positive Bacterial Sepsis (2013-2022) ($MN)
16 Global Sepsis Diagnostics market, By Other Pathogens (2013-2022) ($MN)
17 Global Sepsis Diagnostics market, By Technology (2013-2022) ($MN)
18 Global Sepsis Diagnostics market, By Flow Cytometry (2013-2022) ($MN)
19 Global Sepsis Diagnostics market, By Immunoassays (2013-2022) ($MN)
20 Global Sepsis Diagnostics market, By Microbiology (2013-2022) ($MN)
21 Global Sepsis Diagnostics market, By Molecular Diagnostics (2013-2022) ($MN)
22 Global Sepsis Diagnostics market, By Application (2013-2022) ($MN)
23 Global Sepsis Diagnostics market, By Laboratory Testing (2013-2022) ($MN)
24 Global Sepsis Diagnostics market, By Point-Of-Care Testing (2013-2022) ($MN)
25 North America Sepsis Diagnostics market, By Country (2013-2022) ($MN)
26 North America Sepsis Diagnostics market, By Animal type (2013-2022) ($MN)
27 North America Sepsis Diagnostics market, By Method (2013-2022) ($MN)
28 North America Sepsis Diagnostics market, By Automated Diagnostics (2013-2022) ($MN)
29 North America Sepsis Diagnostics market, By Conventional Diagnostics (2013-2022) ($MN)
30 North America Sepsis Diagnostics market, By Product (2013-2022) ($MN)
31 North America Sepsis Diagnostics market, By Assay Kits & Reagents (2013-2022) ($MN)
32 North America Sepsis Diagnostics market, By Blood Culture Media (2013-2022) ($MN)
33 North America Sepsis Diagnostics market, By Instruments (2013-2022) ($MN)
34 North America Sepsis Diagnostics market, By Software (2013-2022) ($MN)
35 North America Sepsis Diagnostics market, By Pathogen (2013-2022) ($MN)
36 North America Sepsis Diagnostics market, By Fungal Sepsis (2013-2022) ($MN)
37 North America Sepsis Diagnostics market, By Bacterial Sepsis (2013-2022) ($MN)
38 North America Sepsis Diagnostics market, By Gram-Negative Bacterial Sepsis (2013-2022) ($MN)
39 North America Sepsis Diagnostics market, By Gram-Positive Bacterial Sepsis (2013-2022) ($MN)
40 North America Sepsis Diagnostics market, By Other Pathogens (2013-2022) ($MN)
41 North America Sepsis Diagnostics market, By Technology (2013-2022) ($MN)
42 North America Sepsis Diagnostics market, By Flow Cytometry (2013-2022) ($MN)
43 North America Sepsis Diagnostics market, By Immunoassays (2013-2022) ($MN)
44 North America Sepsis Diagnostics market, By Microbiology (2013-2022) ($MN)
45 North America Sepsis Diagnostics market, By Molecular Diagnostics (2013-2022) ($MN)
46 North America Sepsis Diagnostics market, By Application (2013-2022) ($MN)
47 North America Sepsis Diagnostics market, By Laboratory Testing (2013-2022) ($MN)
48 North America Sepsis Diagnostics market, By Point-Of-Care Testing (2013-2022) ($MN)
49 Europe Sepsis Diagnostics market, By Country (2013-2022) ($MN)
50 Europe Sepsis Diagnostics market, By Animal type (2013-2022) ($MN)
51 Europe Sepsis Diagnostics market, By Method (2013-2022) ($MN)
52 Europe Sepsis Diagnostics market, By Automated Diagnostics (2013-2022) ($MN)
53 Europe Sepsis Diagnostics market, By Conventional Diagnostics (2013-2022) ($MN)
54 Europe Sepsis Diagnostics market, By Product (2013-2022) ($MN)
55 Europe Sepsis Diagnostics market, By Assay Kits & Reagents (2013-2022) ($MN)
56 Europe Sepsis Diagnostics market, By Blood Culture Media (2013-2022) ($MN)
57 Europe Sepsis Diagnostics market, By Instruments (2013-2022) ($MN)
58 Europe Sepsis Diagnostics market, By Software (2013-2022) ($MN)
59 Europe Sepsis Diagnostics market, By Pathogen (2013-2022) ($MN)
60 Europe Sepsis Diagnostics market, By Fungal Sepsis (2013-2022) ($MN)
61 Europe Sepsis Diagnostics market, By Bacterial Sepsis (2013-2022) ($MN)
62 Europe Sepsis Diagnostics market, By Gram-Negative Bacterial Sepsis (2013-2022) ($MN)
63 Europe Sepsis Diagnostics market, By Gram-Positive Bacterial Sepsis (2013-2022) ($MN)
64 Europe Sepsis Diagnostics market, By Other Pathogens (2013-2022) ($MN)
65 Europe Sepsis Diagnostics market, By Technology (2013-2022) ($MN)
66 Europe Sepsis Diagnostics market, By Flow Cytometry (2013-2022) ($MN)
67 Europe Sepsis Diagnostics market, By Immunoassays (2013-2022) ($MN)
68 Europe Sepsis Diagnostics market, By Microbiology (2013-2022) ($MN)
69 Europe Sepsis Diagnostics market, By Molecular Diagnostics (2013-2022) ($MN)
70 Europe Sepsis Diagnostics market, By Application (2013-2022) ($MN)
71 Europe Sepsis Diagnostics market, By Laboratory Testing (2013-2022) ($MN)
72 Europe Sepsis Diagnostics market, By Point-Of-Care Testing (2013-2022) ($MN)
73 Asia Pacific Sepsis Diagnostics market, By Country (2013-2022) ($MN)
74 Asia Pacific Sepsis Diagnostics market, By Animal type (2013-2022) ($MN)
75 Asia Pacific Sepsis Diagnostics market, By Method (2013-2022) ($MN)
76 Asia Pacific Sepsis Diagnostics market, By Automated Diagnostics (2013-2022) ($MN)
77 Asia Pacific Sepsis Diagnostics market, By Conventional Diagnostics (2013-2022) ($MN)
78 Asia Pacific Sepsis Diagnostics market, By Product (2013-2022) ($MN)
79 Asia Pacific Sepsis Diagnostics market, By Assay Kits & Reagents (2013-2022) ($MN)
80 Asia Pacific Sepsis Diagnostics market, By Blood Culture Media (2013-2022) ($MN)
81 Asia Pacific Sepsis Diagnostics market, By Instruments (2013-2022) ($MN)
82 Asia Pacific Sepsis Diagnostics market, By Software (2013-2022) ($MN)
83 Asia Pacific Sepsis Diagnostics market, By Pathogen (2013-2022) ($MN)
84 Asia Pacific Sepsis Diagnostics market, By Fungal Sepsis (2013-2022) ($MN)
85 Asia Pacific Sepsis Diagnostics market, By Bacterial Sepsis (2013-2022) ($MN)
86 Asia Pacific Sepsis Diagnostics market, By Gram-Negative Bacterial Sepsis (2013-2022) ($MN)
87 Asia Pacific Sepsis Diagnostics market, By Gram-Positive Bacterial Sepsis (2013-2022) ($MN)
88 Asia Pacific Sepsis Diagnostics market, By Other Pathogens (2013-2022) ($MN)
89 Asia Pacific Sepsis Diagnostics market, By Technology (2013-2022) ($MN)
90 Asia Pacific Sepsis Diagnostics market, By Flow Cytometry (2013-2022) ($MN)
91 Asia Pacific Sepsis Diagnostics market, By Immunoassays (2013-2022) ($MN)
92 Asia Pacific Sepsis Diagnostics market, By Microbiology (2013-2022) ($MN)
93 Asia Pacific Sepsis Diagnostics market, By Molecular Diagnostics (2013-2022) ($MN)
94 Asia Pacific Sepsis Diagnostics market, By Application (2013-2022) ($MN)
95 Asia Pacific Sepsis Diagnostics market, By Laboratory Testing (2013-2022) ($MN)
96 Asia Pacific Sepsis Diagnostics market, By Point-Of-Care Testing (2013-2022) ($MN)
97 RoW Sepsis Diagnostics market, By Country (2013-2022) ($MN)
98 RoW Sepsis Diagnostics market, By Animal type (2013-2022) ($MN)
99 RoW Sepsis Diagnostics market, By Method (2013-2022) ($MN)
100 RoW Sepsis Diagnostics market, By Automated Diagnostics (2013-2022) ($MN)
101 RoW Sepsis Diagnostics market, By Conventional Diagnostics (2013-2022) ($MN)
102 RoW Sepsis Diagnostics market, By Product (2013-2022) ($MN)
103 RoW Sepsis Diagnostics market, By Assay Kits & Reagents (2013-2022) ($MN)
104 RoW Sepsis Diagnostics market, By Blood Culture Media (2013-2022) ($MN)
105 RoW Sepsis Diagnostics market, By Instruments (2013-2022) ($MN)
106 RoW Sepsis Diagnostics market, By Software (2013-2022) ($MN)
107 RoW Sepsis Diagnostics market, By Pathogen (2013-2022) ($MN)
108 RoW Sepsis Diagnostics market, By Fungal Sepsis (2013-2022) ($MN)
109 RoW Sepsis Diagnostics market, By Bacterial Sepsis (2013-2022) ($MN)
110 RoW Sepsis Diagnostics market, By Gram-Negative Bacterial Sepsis (2013-2022) ($MN)
111 RoW Sepsis Diagnostics market, By Gram-Positive Bacterial Sepsis (2013-2022) ($MN)
112 RoW Sepsis Diagnostics market, By Other Pathogens (2013-2022) ($MN)
113 RoW Sepsis Diagnostics market, By Technology (2013-2022) ($MN)
114 RoW Sepsis Diagnostics market, By Flow Cytometry (2013-2022) ($MN)
115 RoW Sepsis Diagnostics market, By Immunoassays (2013-2022) ($MN)
116 RoW Sepsis Diagnostics market, By Microbiology (2013-2022) ($MN)
117 RoW Sepsis Diagnostics market, By Molecular Diagnostics (2013-2022) ($MN)
118 RoW Sepsis Diagnostics market, By Application (2013-2022) ($MN)
119 RoW Sepsis Diagnostics market, By Laboratory Testing (2013-2022) ($MN)
120 RoW Sepsis Diagnostics market, By Point-Of-Care Testing (2013-2022) ($MN)